HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Flaño, E. Articles by Blackman, M. A. Search for Related Content PubMed PubMed Citation Articles by Flaño, E. Articles by Blackman, M. A.

Latent Murine -Herpesvirus Infection Is Established in Activated B Cells, Dendritic Cells, and Macrophages¹

Emilio Flaño^2,*,, S. Mazher Husain^,, Jeffery T. Sample^,,§, David L. Woodland^2,*,,§ and Marcia A. Blackman^2,3,*,,§

Departments of ^* Immunology and Virology and Molecular Biology, and Program in Viral Oncogenesis and Tumor Immunology, St. Jude Children’s Research Hospital, Memphis, TN 38105; and ^§ Department of Pathology, University of Tennessee, Memphis, TN 38163

	Abstract

Top Abstract Introduction Materials and Methods Results Discussion References

 
Intranasal infection of mice with the murine -herpesvirus MHV-68 results in an acute lytic infection in the lung, followed by the establishment of lifelong latency. Development of an infectious mononucleosis-like syndrome correlates with the establishment of latency and is characterized by splenomegaly and the appearance of activated CD8⁺ T cells in the peripheral blood. Interestingly, a large population of activated CD8⁺ T cells in the peripheral blood expresses the Vß4⁺ element in their TCR. In this report we show that MHV-68 latency in the spleen after intranasal infection is harbored in three APC types: B cells, macrophages, and dendritic cells. Surprisingly, since latency has not previously been described in dendritic cells, these cells harbored the highest frequency of latent virus. Among B cells, latency was preferentially associated with activated B cells expressing the phenotype of germinal center B cells, thus formally linking the previously reported association of latency gene expression and germinal centers to germinal center B cells. Germinal center formation, however, was not required for the establishment of latency. Significantly, although three cell types were latently infected, the ability to stimulate Vß4⁺CD8⁺ T cell hybridomas was limited to latently infected, activated B cells.

	Introduction

Top Abstract Introduction Materials and Methods Results Discussion References

 
The -herpesviruses establish a delicate balance between life-long latency in the host and immune control of the infection. Murine -herpesvirus-68 (MHV-68)⁴ is a ₂-herpesvirus that shares biological features and sequence homology with EBV and human herpesvirus-8 (1, 2). MHV-68 provides an excellent mouse model in which host--herpesvirus interactions can be studied. Intranasal infection of mice with MHV-68 causes an acute respiratory infection that is rapidly resolved, followed by the establishment of latency. Levels of latent virus in the spleen peak around 14 days after infection, drop quickly, and remain stable for life in an immunologically competent and genetically unmanipulated animal (3).

Subsequent to the acute phase of the response, MHV-68 infection produces a syndrome similar to EBV-induced infectious mononucleosis in humans. This syndrome is characterized by splenomegaly (1, 4), Ag nonspecific B cell activation (5), and lymphocytosis of the peripheral blood (6). The splenomegaly is a consequence of increased numbers of cycling CD4⁺ T cells, CD8⁺ T cells, and B cells, and the blood lymphocytosis largely reflects increased numbers of activated CD8⁺ T cells (4, 6). A striking feature of MHV-68 infectious mononucleosis-like syndrome is the pronounced expansion of CD8⁺ T cells bearing Vß4⁺TCR (6). This expansion is not MHC restricted (6, 7) and appears to be independent of classical MHC class I or II molecules (7). The identity of the stimulatory ligand for the Vß4⁺CD8⁺ T cell expansion remains elusive, but its expression correlates with peak levels of splenic latency at 2 wk after infection (7, 8).

Analogous to EBV infection, B cells are a principal reservoir of latent MHV-68 after intranasal infection (9, 10, 11), and transfer RNA gene expression associated with latency has been localized to splenic germinal centers (12, 13, 14). Latent MHV-68 has also been described in lung epithelial cells (15) and peritoneal macrophages and B cells (16). Recently, we have described lytic Ag presentation by splenic macrophages, dendritic cells, and B cells at time points after clearance of lytic infection from the lung, but the analysis did not distinguish between persistent lytic virus and latent virus in these cell types (17). The current experiments were initiated to identify the predominant hemopoietic cell types harboring latent virus at the peak of latency and to examine their participation in the activation of Vß4⁺CD8⁺ T cells associated with the establishment of the infectious mononucleosis-like syndrome.

	Materials and Methods

Top Abstract Introduction Materials and Methods Results Discussion References

 
Mice

C57BL/6J (B6) and C57BL/6-CD28^{tm1 Mak} (18) (CD28^-/-) mice were purchased from The Jackson Laboratory (Bar Harbor, ME). Mice were housed under specific pathogen-free conditions before MHV-68 infection at 8–16 wk of age and in biolevel 3 containment after infection. All animal procedures in these experiments were approved by the institutional animal care and use committee at St. Jude Children’s Research Hospital (Memphis, TN).

Virus stocks, infection, and sampling of mice

The stock of MHV-68 (clone G2.4) was obtained from Prof. A. A. Nash (Edinburgh, U.K.), propagated in OMK cells (ATCC 1566CRL, American Type Culture Collection, Manassas, VA), and titrated on NIH-3T3 fibroblast s(ATCC CRL1568, American Type Culture Collection) monolayers, as previously described (3). Mice were anesthetized with 2,2,2-tribromoethanol and infected intranasally with 600 PFU of MHV-68 in a total volume of 40 µl PBS. Splenocytes and/or peripheral blood were analyzed at various times after infection.

The lacZ hybridoma assay

Characterization of Vß4⁺CD8⁺lacZ-inducible T cell hybridomas that specifically respond to MHV-68-infected spleen cells 14 days postinfection has been previously described (7). Ag presentation and development of the histochemical reaction were performed as previously described (7, 8). Briefly, T cell-depleted spleen cells were used as stimulator cells, titrated in 2-fold dilutions, and plated. Representative lacZ-inducible T cell hybridomas 4BH-98 or 5BH-11 were added, incubation proceeded overnight, and ß-galactosidase activity was assessed in individual wells. The background stimulation was determined by using naive APCs as stimulators.

Flow cytometry

After erythrocyte lysis in hemolytic Gey’s solution, cells were stained for FACS analysis using combinations of the following Abs and lectins: CD1d (CD1.1, Ly-38), CD11b (Mac-1), CD11c, CD16/CD32 (FcBlock), CD19, CD23 (IgE FcR), CD25 (IL-2 R), CD38, CD40, CD43 (Ly-48), CD44, CD45R (B220), CD62L, CD69, CD80 (B-7), CD95 (Fas), CD138 (Syndecan-1), TCR Vß4, CD8, IgD^b, IgM, I-A^b, and peanut agglutinin (PNA). All reagents were purchased from PharMingen (San Diego, CA), except CD8 (Caltag, Burlingame, CA) and PNA (Sigma, St. Louis, MO). At least 20,000 live cells were gated and acquired on a FACScan flow cytometer, and the data were analyzed using CellQuest software (Becton Dickinson Immunocytometry Systems, San Jose, CA).

Infective center assay

Infective center assays were performed as previously described (8). Briefly, serial dilutions (in triplicate) of T cell-depleted splenocytes were plated onto monolayers of NIH-3T3 cells and overlaid with carboxymethylcellulose; after 6 days of culture, plaques were quantitated. As this assay also measures lytic virus, the possible contribution of lytic virus to the titers was determined by parallel analysis of cell lysates. Thus, duplicate samples were subjected to a single cycle of freeze/thawing, resuspended, and directly analyzed (without centrifugation) for the development of plaques.

Virus limiting dilution analysis (LDA)

LDA of virus titer was performed as previously described (11, 17), with modifications. Murine embryonic fibroblasts (MEF) were harvested from BALB/c embryos and grown in DMEM supplemented with tumor cocktail (19) and 10% FCS. Serial 2-fold dilutions of splenocytes starting at 5 x 10⁴ cells/well were plated onto MEF monolayers (1.5 x 10⁴/well) in flat-bottom 96-well plates. Twenty-four wells were plated for each dilution. The numbers of wells exhibiting cytopathic effect were counted after 3 wk of culture. The presence of lytic virus was determined as described above by simultaneous analysis of the total cell lysate obtained after a single cycle of freeze/thawing.

Cell purification

FACS sorting was performed on a MoFlo (Cytomation, Fort Collins, CO) or on a FACStar Plus (Becton Dickinson, Mountain View, CA) equipped with a high speed sorting module. Pooled splenocytes from five to seven mice at 14 days after infection were used in all experiments. For B cell sorting, an aliquot of cells was first incubated with FcBlock and then stained with FITC-conjugated anti-CD11c, PE-conjugated anti-CD11b, and Cy-Chrome-conjugated anti-B220. B cells (B220⁺, CD11b^-, CD11c^-) were sorted. To control for loss of virus titer or stimulatory activity that might result from the binding of Abs and/or from the physical stress of the sorting, cells were stained and mock sorted as single viable cells. At the same time and to avoid B cell cross-contamination, the rest of the sample was B cell-depleted using anti-B220 and a mixture of anti-rat and anti-mouse Ig Dynabeads (Dynal, Oslo, Norway). The remaining population was stained as described above and sorted as macrophages (B220^-, CD11b⁺, CD11c^-) or dendritic cells (B220^-, CD11b^-, CD11c⁺). After magnetic depletion the quantity of B cells in the remaining population was <0.01%, and the purity of the sorted populations was >99%. For activated/resting B cell sorting, spleen cells were incubated with FcBlock and then stained with FITC-conjugated PNA and Cy-Chrome-conjugated anti-B220. Activated B cells were sorted as PNA^highB220⁺, and resting B cells were sorted as PNA^lowB220⁺. The purities of the sorted populations were >95%.

Spleen cells were depleted of T and B cells according to the following protocol. B cells were depleted by magnetic sorting as described above, followed by incubation with the IgM anti-Thy1 mAb AT83 (20) and a mixture of rabbit and guinea pig complement (Cedarlane, Ontario, Canada) to deplete T cells. The percentage of B cells in the final population was <0.5%.

Germinal center B cells were enriched as previously described (21) with modifications. Splenocytes were Fc-blocked and stained with a cocktail of biotinylated Abs to CD11b, CD11c, Ly-6G (GR-1), Ter119 (Ly-76), CD3, CD4, CD8, DX5, IgD, and CD138 (PharMingen). After washing, cells were depleted using streptavidin-conjugated Dynabeads (Dynal). The resulting cells were enriched 2- to 5-fold for germinal center B cells as judged by staining with PNA and anti-B220.

	Results

Top Abstract Introduction Materials and Methods Results Discussion References

 
A high frequency of splenic dendritic cells is latently infected

In a previous report we described the presentation of MHV-68 lytic cycle protein epitopes by splenic B cells, macrophages, and dendritic cells at a time after infection corresponding to the peak of splenic latency (17). An infective center assay confirmed that this was due to the presence of cell-associated virus rather than persistence of Ag-loaded APC, but we did not distinguish whether the virus was produced as a consequence of reactivation from latency or persistent lytic infection. It has previously been shown that B cells and peritoneal macrophages harbor latent virus (9, 10, 11, 16), but latency has not been described in splenic macrophages or dendritic cells. Therefore, the present studies were initiated to determine whether splenic macrophages and dendritic cells harbor latent MHV-68 and, if so, to determine the frequency of latency in each of these cell types.

To analyze the presence of latent virus in the three different cell populations, splenocytes isolated from MHV-68-infected mice at 14 days after infection were FACS-sorted into purified populations of B cells (B220⁺, CD11b^-, CD11c^-), macrophages (B220^-, CD11b⁺, CD11c^-), and dendritic cells (B220^-, CD11b^-, CD11c⁺). Analysis was performed at 14 days postinfection because at this time point latent virus is at peak levels, and lytic virus is largely cleared (3, 22, 23). Latent virus in these purified populations was quantitated by LDA of in vitro virus reactivation (11). Thus, sorted cell populations were plated onto monolayers of MEF to allow in vitro reactivation of MHV-68, and the resulting virus-induced cytopathic effect was quantitated 3 wk later. Data were plotted as the percentage of wells positive for cytopathic effect at each cell concentration per well (Fig. 1), and linear regression analysis was used to determine the frequency of latently infected cells (Table I). As expected from previous reports (9, 10, 11, 16), latent reactivatable virus was detected in macrophages and B cells, but, unexpectedly, the highest frequency of latent virus was found in the dendritic cell population (Table I). In fact, the frequency of latent infection in dendritic cells was 7-fold greater than that in B cells. Taking into account the relative representation of each of the three cell types, approximately equivalent numbers of latently infected B cells and dendritic cells exist in the spleen (Table I).

View larger version (22K): [in this window] [in a new window]   FIGURE 1. B cells, macrophages, and dendritic cells in the spleen harbor latent MHV-68. An LDA to detect reactivation from latency was performed on spleen cells 14 days after infection. Data are presented as the percentage of wells that scored positive for viral cytopathic effect as a function of the number of cells plated per well, 3 wk after plating. Spleen cells were analyzed directly (A), FACS-stained and mock-sorted (B), or sorted as B cells (B220+CD11b-CD11c-; C), dendritic cells (B220-CD11b-CD11c+; D), or macrophages (B220- CD11b+CD11c-; E). Lytic (infectious) virus results were obtained from duplicate samples when the cells were lysed by freeze/thawing before plating. The data presented are the average of two independent experiments, representative of four experiments with similar results, each analyzing pooled spleens from seven mice.

In the course of these studies we discovered that the sorting procedure lowered the reactivation frequency of latently infected cells. Mock sorting controls in which cells were stained and then sorted as single viable cells showed an approximately 5-fold decrease in virus reactivation compared with unsorted cells (Fig. 1, A and B), although the cell viability of the sorted populations was 99% at the time of plating. Apparently, stress induced by sorting has a dramatic effect on the ability to detect latently MHV-68-infected cells, at least as measured by this assay. Therefore, the frequencies obtained for FACS-sorted cells should be considered the lower limit of the true reactivatable frequency. Importantly, this control rules out the possibility that Ab binding has caused increased levels of reactivation.

Activated B cells are the major B cell reservoir of MHV-68 at the peak of latency

The high levels of expression of the MHV-68 transfer RNA-like genes (a marker of latency) associated with germinal centers and primary follicles during MHV-68 latency (12, 13, 14) raised the possibility that latency may be associated preferentially with germinal center B cells, but this has not been formally shown. Therefore, we also analyzed latency among different subpopulations of B cells. PNA was used as a marker for activated/germinal center B cells (25). To confirm the germinal center phenotype of the isolated B220⁺PNA^high cells, the expression of different activation markers and B cell Ags in spleen cells analyzed at the same time after infection was determined. As is shown in Fig. 2, B220⁺PNA^high B cells were blasted, CD19⁺, CD80⁺, CD44^high, CD23^low, CD95⁺ cells, expressing high levels of I-A^b and low levels of IgD, and showed heterogeneous down-regulation of CD38, all hallmarks of germinal center B cells (26, 27). Moreover, they expressed markers of activated/cycling B cells (CD25^high, CD43^high, CD62L^low, CD69^high), and they were negative for expression of Syndecan-1 (CD138; data not shown). Note that these cells exhibited high levels of expression of CD40, a phenotype related to B cell survival and rescue from apoptosis (28, 29).

View larger version (42K): [in this window] [in a new window]   FIGURE 2. Phenotypic analysis of splenic B cells 14 days after infection. B cells expressing PNA at high or low density were analyzed for the expression of the following cell surface molecules and characteristics: I-Ab, IgD, B220, CD1d, CD19, CD23, CD25, CD38, CD40, CD43, CD44, CD62L, CD69, CD80, CD95, forward scatter, and side scatter.

View larger version (18K): [in this window] [in a new window]   FIGURE 3. Activated, PNAhigh B cells contain most of the latent virus in the B cell population. Latently infected cells were assessed in FACS-sorted PNAhigh () and PNAlow () subsets of splenic B cells () 14 days after infection by LDA, as described in Fig. 1. The data presented are from a single experiment representative of three independent experiments with similar results, each analyzing pooled spleens from seven mice.

The ligand driving the expansion of Vß4⁺CD8⁺ T cells, a key feature of the infectious mononucleosis-like phase of MHV-68 infection, has not been identified. However, we are able to assess ligand expression by the ability to stimulate a panel of Vß4⁺CD8⁺ T cell hybridomas generated from latently infected mice during the infectious mononucleosis-like phase of infection. Using this approach, we have previously shown that the Vß4⁺CD8⁺ T cell stimulatory activity was expressed by T cell-depleted spleen cells isolated from MHV-68-infected mice at the peak of latency (7). Furthermore, FACS-sorted B220⁺ cells expressed the stimulatory activity. The observation here that B cell latency was preferentially associated with activated B cells made it important to test whether the Vß4⁺CD8⁺-stimulatory activity was expressed by activated, but not resting, B cells. First, using representative Vß4⁺CD8⁺ T cell hybridomas, we tested the stimulatory capacity of B cells that had been enriched for germinal center cells by a non-flow cytometric-based negative depletion protocol compared with T cell-depleted spleen cells from day 14-infected mice. The data indicated that there was an approximately 2-fold increase in stimulation of a representative T cell hybridoma (Fig. 4A) that correlated with the increase in latency as measured by the infective center assay (Fig. 4B) and was consistent with the approximately 2-fold increase in germinal center B cells attained in this experiment. Second, we directly compared the stimulatory ability of sorted populations of PNA^high and PNA^low B cells. The data (Fig. 5) show that despite the fact that latent virus is associated both with PNA^high and PNA^low B cells, albeit at different frequencies (Table I), the Vß4 hybridoma stimulatory activity resided exclusively in the activated, PNA^high B cell population.

View larger version (24K): [in this window] [in a new window]   FIGURE 4. Germinal center B cells have increased Vß4+CD8+ T cell stimulatory capacity, which correlates with an increase in MHV-68 latency. A, The ability of T cell-depleted spleen cells () and germinal center-enriched B cells (; see Materials and Methods) 14 days after infection to stimulate a representative Vß4+CD8+ T cell hybridoma (5BH-11) is shown. Naive T cell-depleted spleen cells () were used as negative controls. B, Latent viral titers in T cell-depleted spleen cells and germinal center-enriched B cells at 14 days after infection were estimated by an infective center assay. The infective center numbers are the mean values of triplicate wells. Error bars represent the SD.

View larger version (23K): [in this window] [in a new window]   FIGURE 5. Activated B cells present the ligand that stimulates Vß4+CD8+ T cell hybridomas. Stimulation of a representative MHV-68-specific Vß4+CD8+ hybridoma (4BH-98) by T-depleted spleen cells () 14 days after infection. B cell subsets were FACS sorted as germinal center B cells (B220+PNAhigh; ) or follicular B cells (B220+PNAlow; •). Naive T cell-depleted spleen cells () were used as negative controls.

View larger version (26K): [in this window] [in a new window]   FIGURE 6. T cell- and B cell-depleted splenocytes do not express the ligand that stimulates Vß4+CD8+ T cell hybridomas. The ability of spleen cells 14 days after infection to stimulate a representative Vß4+CD8+ T cell hybridoma (4BH-98) was assessed. Spleen cells from MHV-68-infected mice were tested directly () or following T cell depletion (), T cell and B cell depletion (), or germinal center cell enrichment (•) as described in Materials and Methods. The percentage of B cells in the T/B-depleted population was <0.5%. Naive splenocytes that were unseparated (), T cell depleted (), or T cell and B cell depleted () were used as controls.

Germinal center formation is not required for the establishment of latency or Vß4⁺CD8⁺ T cell stimulation

The high levels of latency in activated B cells and the association of latent gene expression with germinal centers (12, 13, 14) raised the possibility that MHV-68 uses the normal germinal center reaction for the establishment/maintenance of latency, as has been proposed for EBV (30). To test the requirement for germinal center formation in establishing latency and in the generation of Vß4⁺CD8⁺ T cell-stimulatory activity, we analyzed MHV-68-infected CD28^-/- mice. CD28^-/- mice have been shown to be deficient in germinal center formation and to have defective T cell activation (31). Comparative analysis of infected B6 and CD28^-/- mice showed that although the percentages of B cells in the spleen are similar in both mouse models (Fig. 7A), the CD28^-/- mice do not show a corresponding increase in the number of PNA^high B cells (Fig. 7B). Thus, MHV-68 causes the expected increase in numbers of B cells in the spleen characteristic of MHV-68-induced splenomegaly, but the activated B cells do not differentiate into germinal center B cells. Analysis of T cell activation in the two strains showed that the lymphocytosis of the peripheral blood was not dependent on CD28, as the numbers of CD8⁺ T cells increased comparably (Fig. 8A). In addition, there was no difference in expression of the Vß4 stimulatory ligand, as there were comparable levels of Vß4⁺CD8⁺ T cell expansion in the peripheral blood (Fig. 8B) and spleen (data not shown), and T cell-depleted spleen cells from day 14-infected mice stimulated a representative Vß4⁺CD8⁺ T cell hybridoma to comparable levels (Fig. 8C). Finally, the absence of CD28 did not prevent the establishment of latency on day 14 (Fig. 9). The decreased levels of infective centers in the CD28^-/- mice may reflect the reduced pool of activated B cells in these mice (Fig. 7B), although the observation that the levels in CD28^-/- mice are progressively lower at 14 and 21 days after infection is intriguing and may indicate that there is a defect in the maintenance of latency. Long term experiments are in progress to address this possibility. Thus, the data show that germinal center formation per se is not required for B cell proliferation, stimulation of Vß4⁺CD8⁺ T cells, or establishment of latency.

View larger version (23K): [in this window] [in a new window]   FIGURE 7. Comparison of B cell activation in MHV-68-infected B6 and CD28-/- mice. B6 and CD28-/- mice were assessed for the percentage of CD19+ splenic B cells (A) and levels of activated, PNAhigh B cells (B) before infection (naive) and at 14 and 21 days after MHV-68 infection. Error bars correspond to the SD. The p values for the differences in the percentage of activated cells between B6 and CD28-/- mice at 14 and 21 days postinfection, determined by the Mann-Whitney test, are 0.01 and 0.05, respectively.

View larger version (23K): [in this window] [in a new window]   FIGURE 8. MHV-68-induced Vß4+CD8+ T cell activation/expansion are not dependent on CD28. B6 and CD28-/- mice were assessed for the percentage of CD8+ T cells among total blood lymphocytes (A) and the percentage of Vß4+ T cells among CD8+ T cells (B) before (naive) and 14 and 21 days after MHV-68 infection. C, The ability of T cell-depleted spleen cells from B6 () and CD28-/- (•) mice at 14 days after MHV-68 infection to stimulate a representative Vß4+ T cell hybridoma, 4BH-98, was assessed. T cell-depleted splenocytes from naive B6 () and CD28-/- () mice were used as controls. Error bars represent the SD.

View larger version (15K): [in this window] [in a new window]   FIGURE 9. MHV-68 splenic latency in B6 and CD28-/- mice. Latent viral titers in T cell-depleted spleen cells at 14 and 21 days after infection were estimated by an infective center assay. The infective center numbers are the mean values of triplicate wells assessed in at least two separate experiments. Error bars represent the SD. The p values for the differences between B6 and CD28-/- mice at 14 and 21 days postinfection, determined by the Mann-Whitney test, are both 0.001.

	Discussion

Top Abstract Introduction Materials and Methods Results Discussion References

The identification of dendritic cells and splenic macrophages as reservoirs of latent MHV-68 virus after intranasal infection is an exciting and novel finding. Therefore, it is important to formally demonstrate that the virus is truly latent and not due to slow, chronic lytic infection. Unfortunately, latency gene expression is in the early stages of characterization, and it is not yet possible to use expression of diagnostic latency genes to define latency. Recent evidence suggests that MHV-68 may have a complex program of latency gene expression, analogous to EBV (32), as different patterns of expression of putative latency genes were shown in different organs (33). Although we have recently reported that the expression of M2 is latency associated, nothing is known about the cell type specificity of M2 expression (34). In the absence of a molecular definition of latency, the LDA viral reactivation assay has been carefully developed and used to distinguish lytic from latent virus (11, 16, 23). Importantly, this assay is approximately 10-fold more sensitive for detecting lytic virus in disrupted cells than the standard plaque assay, as the prolonged incubation time allows sufficient time for the outgrowth of preformed infectious virus (11, 24). Therefore, in the absence of a molecular definition of latency, it is reasonable to conclude that the virus detected in dendritic cells and macrophages is latent, although we acknowledge that it is formally possible that the assay fails to detect slow, chronic viral replication as lytic virus.

Macrophages, dendritic cells, and activated B cells constitute the APC of the immune system, which are responsible for initiation of Ag-specific responses. The observation here that all three types of APC harbor latent virus may have important implications for the ability of host immune responses to control reactivation from latency. Latently infected macrophages, dendritic cells, and B cells have the potential to be targets of the immune response, and latent infection might interfere with cytokine synthesis or cell surface Ag expression, resulting in modulation of the host immune response and favoring viral persistence.

The current studies show that a high frequency of dendritic cells harbors latent virus. Taking into account the absolute numbers of B cells and dendritic cells, the two cell types constitute approximately equal pools of splenic latency in intranasally infected mice, although we cannot rule out the possibility that the flow cytometry-associated reduction in latency levels detected by in vitro reactivation assays is different for the two cell types. The high frequency of latency in dendritic cells in this study makes it somewhat surprising that latency had not previously been identified in dendritic cells. Whereas early studies suggested the presence of a latently infected adherent cell population (9), subsequent studies in B cell-deficient µMT mice were consistent with the conclusion that B cells were the exclusive latently infected cell type in the spleens of intranasally infected mice (35). However, the observation that B cells are required for the establishment of splenic infection (after intranasal infection) provides a likely explanation for the absence of other latently infected cell types in the spleens of µMT mice (11, 15, 35).

The observation that dendritic cells harbor latent virus raises the question of whether these cells are also targets for lytic infection. Dendritic cells are extremely efficient at stimulating primary T cell responses, because of their ability to secrete chemokines that attract naive T cells; their high density expression of MHC molecules, MHC/peptide complexes, and costimulatory molecules; and their ability to secrete high levels of IL-12 (36). Thus, viral Ag presentation by infected dendritic cells might have important implications for the initiation of the acute anti-viral response. This possibility warrants further investigation.

Despite the fact that B cells are not the only latently infected cell type, they clearly play a unique role in latent MHV-68 infection. First, they appear to be required for trafficking of MHV-68 to the spleen after intranasal infection (15). Second, they appear to control virus reactivation and chronic infection (23). Third, the current results show that they are the only latently infected cell type capable of activating Vß4⁺CD8⁺ T cell hybridomas. Identification of potential specific roles for latently infected macrophages and dendritic cells requires further investigation.

The finding that activated B cells are unique in their expression of the Vß4⁺CD8⁺ T cell stimulatory ligand is consistent with previous reports that in vivo Vß4 expansion is dependent on the presence of CD4⁺ T cells, B cells, and CD40L (8, 37). It is somewhat surprising that Vß4 expansion is not also dependent on CD28 expression, as both CD28/B7 and CD40L/CD40 signaling pathways play critical roles in B cell responses, and early studies suggested that CD28 ligation was required for induction of CD40L expression (38). However, more recently it has been shown that TCR triggering alone can induce CD40L expression (39, 40). Clearly, Vß4 expansion occurs in CD28^-/- mice, and although germinal center B cells are not formed, B cells have been activated in the sense that they expand in number comparably to B6 mice. The data indicate that although Vß4 stimulatory activity is preferentially associated with latently infected PNA^high B cells in B6 mice, full progression to germinal center formation is not required for expression of the stimulatory ligand in activated B cells.

The exclusive ability of activated B cells to stimulate Vß4⁺CD8⁺ T cell hybridomas also has significant implications for understanding the nature of the stimulatory ligand. Previous studies showing that presentation of the ligand appears to be independent of MHC molecules (7) indicate that the ligand is unusual. There are several possible explanations for the selective ligand expression in activated B cells. First, it is possible that the exclusive expression of the ligand by B cells reflects cell-specific patterns of latent gene expression (33), analogous to the multiple forms of latency in EBV (32). A more complete understanding of the genes expressed during MHV-68 latency will be required to test this idea. Second, there may be differential Ag processing of the uncharacterized Vß4 ligand in B cells. For example, B cells preferentially present Ags internalized by the B cell Ig receptor (41, 42). Third, it is possible that the Vß4 ligand is a self molecule, such as a B cell activation marker, that is up-regulated to sufficient levels during infection to exceed established tolerance.

The association between activated B cells and latency described in this report is consistent with the possibility that the establishment of MHV-68 latency in mice is similar to the process described for EBV, in that establishment/maintenance of viral latency may exploit the normal germinal center reaction. Although our data show that latency can be established in the absence of the germinal centers in CD28^-/- mice, an important question is whether long term MHV-68 latency requires the generation of memory cells, a germinal center-dependent function, as it has been shown that EBV persists in memory B cells (30). The pool of resting B cells that harbor latent virus identified in the current study could represent memory B cells, in which long term latency may be maintained. Therefore, it will be important to examine long term latency in CD28^-/- and other mice incapable of germinal center formation and/or incapable of generating memory B cells. Another interesting possibility that warrants further investigation is that MHV-68 infection allows formation of germinal centers in CD28^-/- mice by bypassing the normal requirements for T cell help in the establishment of germinal centers. Although it has been shown in VSV-infected CD28^-/- mice that germinal centers are not formed in the absence of T cell help (18), this has not been examined directly in MHV-68-infected mice.

CD28^-/- mice have also been reported to be deficient in T cell activation, although the absence of T cell costimulation can be compensated by the strength of the signal, which is affected by Ag density, or by alternative costimulatory signals (reviewed in Ref. 38). Although the current studies did not directly assess the requirement for CD28 in the initial stages of T cell activation in response to acute viral infection, the T cell profile during the infectious mononucleosis phase of the response in terms of activation/expansion of both CD8⁺ T cells and Vß4⁺CD8⁺ T cells was comparable in B6 and CD28^-/- mice. It is likely that the acute T cell response is initiated normally, particularly in light of the possibility that dendritic cells may be lytically infected, as dendritic cells are potent APC and would probably bypass the requirement for CD28 in initiating the anti-viral T cell response.

In conclusion, the finding that MHV-68 establishes latency in multiple cell types, including B cells, macrophages, dendritic cells, and lung epithelial cells, is in accordance with similar findings for human herpesviruses such as EBV, CMV, and Kaposi sarcoma-associated herpesvirus (32, 43, 44, 45, 46, 47). Despite this, B cells appear to play the pivotal role in both the establishment and maintenance of latency and in triggering the expansion of Vß4⁺CD8⁺ T cells during the infectious mononucleosis stage of infection. MHV-68 infection of mice provides an excellent experimental model system for determining the significance of discrete reservoirs of latency in cells other than B cells.

	Acknowledgments

 
We thank Richard Cross for sorting the cells; Herbert W. Virgin IV (Washington University School of Medicine, St. Louis, MO) for advice on the virus/LDA protocol and for supplying us with our initial source of MEF cells; Fran Lund (Trudeau Institute, Saranac Lake, NY), Charles Hardy, Edward Usherwood, In-Jeong Kim, and James Stewart (University of Edinburgh, Edinburgh, U.K.) for helpful discussions; and Phuong Nguyen for technical assistance.

	Footnotes

 
¹ This work was supported by National Institutes of Health Grants AI42927 (to M.A.B.), CA56639 (to J.T.S.), and P30CA21765 (CORE grant) and the American Lebanese Syrian Associated Charities.

² Current address: Trudeau Institute, 100 Algonquin Avenue, Saranac Lake, NY 12983.

³ Address correspondence and reprint requests to Dr. Marcia A. Blackman, Trudeau Institute, 100 Algonquin Avenue, Saranac Lake, NY 12983.

⁴ Abbreviations used in this paper: MHV-68, murine -herpesvirus-68; i.n., intranasal; X-gal, 5-bromo-4-chloro-3-indolyl-ß-D-galactopyranoside; PNA, peanut agglutinin; MEF, murine embryonic fibroblast; LDA, limiting dilution analysis; CD40L, CD40 ligand.

Received for publication December 3, 1999. Accepted for publication April 24, 2000.

	References

Top Abstract Introduction Materials and Methods Results Discussion References

 

1. Nash, A. A., N. P. Sunil-Chandra. 1994. Interactions of the murine gammaherpesvirus with the immune system. Curr. Opin. Immunol. 6:560.[Medline]
2. Virgin, H. W., P. Latreille, P. Wamsley, K. Hallsworth, K. E. Weck, A. J. Dal Canto, S. H. Speck. 1997. Complete sequence and genomic analysis of murine gammaherpesvirus 68. J. Virol. 71:5894.[Abstract]
3. Cardin, R. D., J. W. Brooks, S. R. Sarawar, P. C. Doherty. 1996. Progressive loss of CD8⁺ T cell-mediated control of a -herpesvirus in the absence of CD4⁺ T cells. J. Exp. Med. 184:863.[Abstract/Free Full Text]
4. Usherwood, E. J., A. J. Ross, D. J. Allen, A. A. Nash. 1996. Murine gammaherpesvirus-induced splenomegaly: a critical role for CD4 T cells. J. Gen. Virol. 77:627.[Abstract/Free Full Text]
5. Stevenson, P. G., P. C. Doherty. 1999. Non-antigen-specific B-cell activation following murine gammaherpesvirus infection is CD4 independent in vitro but CD4 dependent in vivo. J. Virol. 73:1075.[Abstract/Free Full Text]
6. Tripp, R. A., A. M. Hamilton-Easton, R. D. Cardin, P. Nguyen, F. G. Behm, D. L. Woodland, P. C. Doherty, M. A. Blackman. 1997. Pathogenesis of an infectious mononucleosis-like disease induced by a murine -herpesvirus: role for a viral superantigen?. J. Exp. Med. 185:1641.[Abstract/Free Full Text]
7. Coppola, M. A., E. Flaño, P. Nguyen, C. L. Hardy, R. D. Cardin, N. Shastri, D. L. Woodland, M. A. Blackman. 1999. Apparent MHC-independent stimulation of CD8⁺ T cells in vivo during latent murine gammaherpesvirus infection. J. Immunol. 163:1481.[Abstract/Free Full Text]
8. Flaño, E., D. L. Woodland, M. A. Blackman. 1999. Requirement for CD4⁺ T cells in Vß4⁺CD8⁺ T cell activation associated with latent murine gammaherpesvirus infection. J. Immunol. 163:3403.[Abstract/Free Full Text]
9. Sunil-Chandra, N. P., S. Efstathiou, A. A. Nash. 1992. Murine gammaherpesvirus 68 establishes a latent infection in mouse B lymphocytes in vivo. J. Gen. Virol. 73:3275.[Abstract/Free Full Text]
10. Sunil-Chandra, N. P., S. Efstathiou, A. A. Nash. 1993. Interactions of murine gammaherpesvirus 68 with B and T cell lines. Virology 193:825.[Medline]
11. Weck, K. E., M. L. Barkon, L. I. Yoo, S. H. Speck, H. I. Virgin. 1996. Mature B cells are required for acute splenic infection, but not for establishment of latency, by murine gammaherpesvirus 68. J. Virol. 70:6775.[Abstract/Free Full Text]
12. Bowden, R. J., J. P. Simas, A. J. Davis, S. Efstathiou. 1997. Murine gammaherpesvirus 68 encodes tRNA-like sequences which are expressed during latency. J. Gen. Virol. 78:1675.[Abstract]
13. Simas, J. P., R. J. Bowden, V. Paige, S. Efstathiou. 1998. Four tRNA-like sequences and a serpin homologue encoded by murine gammaherpesvirus 68 are dispensable for lytic replication in vitro and latency in vivo. J. Gen. Virol. 79:149.[Abstract]
14. Simas, J. P., S. Efstathiou. 1998. Murine gammaherpesvirus 68: a model for the study of gammaherpesvirus pathogenesis. Trends Microbiol. 6:276.[Medline]
15. Stewart, J. P., E. J. Usherwood, A. Ross, H. Dyson, T. Nash. 1998. Lung epithelial cells are a major site of murine gammaherpesvirus persistence. J. Exp. Med. 187:1941.[Abstract/Free Full Text]
16. Weck, K. E., S. S. Kim, H. I. Virgin, S. H. Speck. 1999. Macrophages are the major reservoir of latent murine gammaherpesvirus 68 in peritoneal cells. J. Virol. 73:3273.[Abstract/Free Full Text]
17. Liu, L., E. Flaño, E. J. Usherwood, S. Surman, M. A. Blackman, D. L. Woodland. 1999. Lytic cycle T cell epitopes are expressed in two distinct phases during MHV-68 infection. J. Immunol. 163:868.[Abstract/Free Full Text]
18. Shahinian, A., K. Pfeffer, K. P. Lee, T. M. Kundig, K. Kishihara, A. Wakeham, K. Kawai, P. S. Ohashi, C. B. Thompson, T. W. Mak. 1993. Differential T cell costimulatory requirements in CD28-deficient mice. Science 261:609.[Abstract/Free Full Text]
19. Kappler, J. W., B. Skidmore, J. White, P. Marrack. 1981. Antigen-inducible, H-2-restricted, interleukin-2-producing T cell hybridomas: lack of independent antigen and H-2 recognition. J. Exp. Med. 153:1198.[Abstract/Free Full Text]
20. Sarmiento, M., A. L. Glasebrook, F. W. Fitch. 1980. IgG or IgM monoclonal antibodies reactive with different determinants on the molecular complex bearing Lyt 2 antigen block T cell-mediated cytolysis in the absence of complement. J. Immunol. 125:2665.[Abstract]
21. Randall, T. D., A. W. Heath, L. Santos-Argumedo, M. C. Howard, I. L. Weissman, F. E. Lund. 1998. Arrest of B lymphocyte terminal differentiation by CD40 signaling: mechanism for lack of antibody-secreting cells in germinal centers. Immunity 8:733.[Medline]
22. Ehtisham, S., N. P. Sunil-Chandra, A. A. Nash. 1993. Pathogenesis of murine gammaherpesvirus infection in mice deficient in CD4 and CD8 T cells. J. Virol. 67:5247.[Abstract/Free Full Text]
23. Weck, K. E., S. S. Kim, H. I. Virgin, S. H. Speck. 1999. B cells regulate murine gammaherpesvirus 68 latency. J. Virol. 73:4651.[Abstract/Free Full Text]
24. Virgin, H. W., S. H. Speck. 1999. Unraveling immunity to gamma-herpesviruses: a new model for understanding the role of immunity in chronic virus infection. Curr. Opin. Immunol. 11:371.[Medline]
25. Kraal, G., I. L. Weissman, E. C. Butcher. 1982. Germinal centre B cells: antigen specificity and changes in heavy chain class expression. Nature 298:377.[Medline]
26. Oliver, A. M., F. Martin, J. F. Kearney. 1997. Mouse CD38 is down-regulated on germinal center B cells and mature plasma cells. J. Immunol. 158:1108.[Abstract]
27. Ridderstad, A., D. M. Tarlinton. 1998. Kinetics of establishing the memory B cell population as revealed by CD38 expression. J. Immunol. 160:4688.[Abstract/Free Full Text]
28. Foy, T. M., J. D. Laman, J. A. Ledbetter, A. Aruffo, E. Claassen, R. J. Noelle. 1994. gp39-CD40 interactions are essential for germinal center formation and the development of B cell memory. J. Exp. Med. 180:157.[Abstract/Free Full Text]
29. Parry, S. L., J. Hasbold, M. Holman, G. G. Klaus. 1994. Hypercross-linking surface IgM or IgD receptors on mature B cells induces apoptosis that is reversed by costimulation with IL-4 and anti- CD40. J. Immunol. 152:2821.[Abstract]
30. Babcock, G. J., L. L. Decker, M. Volk, D. A. Thorley-Lawson. 1998. EBV persistence in memory B cells in vivo. Immunity 9:395.[Medline]
31. Ferguson, S. E., S. Han, G. Kelsoe, C. B. Thompson. 1996. CD28 is required for germinal center formation. J. Immunol. 156:4576.[Abstract]
32. Kieff, E.. 1996. Epstein-Barr virus and its replication. , , ed. Fields Virology 2343. Lippincott-Raven, Philadelphia.
33. Virgin, H. W., R. M. Presti, X. Y. Li, C. Liu, S. H. Speck. 1999. Three distinct regions of the murine gammaherpesvirus 68 genome are transcriptionally active in latently infected mice. J. Virol. 73:2321.[Abstract/Free Full Text]
34. Husain, S. M., E. J. Usherwood, H. Dyson, C. Coleclough, M. A. Coppola, D. L. Woodland, M. A. Blackman, J. P. Stewart, J. T. Sample. 1999. Murine gammaherpesvirus M2 gene is latency-associated and its protein a target for CD8⁺ T lymphocytes. Proc. Natl. Acad. Sci. USA 96:7508.[Abstract/Free Full Text]
35. Usherwood, E. J., J. P. Stewart, K. Robertson, D. J. Allen, A. A. Nash. 1996. Absence of splenic latency in murine gammaherpesvirus 68-infected B cell-deficient mice. J. Gen. Virol. 77:2819.[Abstract/Free Full Text]
36. Klagge, I. M., S. Schneider-Schaulies. 1999. Virus interactions with dendritic cells. J. Gen. Virol. 80:823.[Medline]
37. Brooks, J. W., A. M. Hamilton-Easton, J. P. Christensen, R. D. Cardin, C. L. Hardy, P. C. Doherty. 1999. Requirement for CD40 ligand, CD4⁺ T cells, and B cells in an infectious mononucleosis-like syndrome. J. Virol. 73:9650.[Abstract/Free Full Text]
38. Lenschow, D. J., T. L. Walunas, J. A. Bluestone. 1996. CD28/B7 system of T cell costimulation. Annu. Rev. Immunol. 14:233.[Medline]
39. Roy, M., A. Aruffo, J. Ledbetter, P. Linsley, M. Kehry, R. Noelle. 1995. Studies on the interdependence of gp39 and B7 expression and function during antigen-specific immune responses. Eur. J. Immunol. 25:596.[Medline]
40. Klaus, S. J., L. M. Pinchuk, H. D. Ochs, C. L. Law, W. C. Fanslow, R. J. Armitage, E. A. Clark. 1994. Costimulation through CD28 enhances T cell-dependent B cell activation via CD40-CD40L interaction. J. Immunol. 152:5643.[Abstract]
41. Rock, K. L., B. Benacerraf, A. K. Abbas. 1984. Antigen presentation by hapten-specific B lymphocytes. I. Role of surface immunoglobulin receptors. J. Exp. Med. 160:1102.[Abstract/Free Full Text]
42. Lanzavecchia, A.. 1985. Antigen-specific interaction between T and B cells. Nature 314:537.[Medline]
43. Pollock, J. L., R. M. Presti, S. Paetzold, H. W. T. Virgin. 1997. Latent murine cytomegalovirus infection in macrophages. Virology 227:168.[Medline]
44. Koffron, A. J., M. Hummel, B. K. Patterson, S. Yan, D. B. Kaufman, J. P. Fryer, F. P. Stuart, M. I. Abecassis. 1998. Cellular localization of latent murine cytomegalovirus. J. Virol. 72:95.[Abstract/Free Full Text]
45. Staskus, K. A., W. Zhong, K. Gebhard, B. Herndier, H. Wang, R. Renne, J. Beneke, J. Pudney, D. J. Anderson, D. Ganem, et al 1997. Kaposi’s sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells. J. Virol. 71:715.[Abstract]
46. Cesarman, E., P. S. Moore, P. H. Rao, G. Inghirami, D. M. Knowles, Y. Chang. 1995. In vitro establishment and characterization of two acquired immunodeficiency syndrome-related lymphoma cell lines (BC-1 and BC-2) containing Kaposi’s sarcoma-associated herpesvirus-like (KSHV) DNA sequences. Blood 86:2708.[Abstract/Free Full Text]
47. Decker, L. L., P. Shankar, G. Khan, R. B. Freeman, B. J. Dezube, J. Lieberman, D. A. Thorley-Lawson. 1996. The Kaposi sarcoma-associated herpesvirus (KSHV) is present as an intact latent genome in KS tissue but replicates in the peripheral blood mononuclear cells of KS patients. J. Exp. Med. 184:283.[Abstract/Free Full Text]

This article has been cited by other articles:

				C. M. Collins, J. M. Boss, and S. H. Speck Identification of Infected B-Cell Populations by Using a Recombinant Murine Gammaherpesvirus 68 Expressing a Fluorescent Protein J. Virol., July 1, 2009; 83(13): 6484 - 6493. [Abstract] [Full Text] [PDF]

				K. S. Lee, S. D. Groshong, C. D. Cool, B. K. Kleinschmidt-DeMasters, and L. F. van Dyk Murine Gammaherpesvirus 68 Infection of IFN{gamma} Unresponsive Mice: A Small Animal Model for Gammaherpesvirus-Associated B-Cell Lymphoproliferative Disease Cancer Res., July 1, 2009; 69(13): 5481 - 5489. [Abstract] [Full Text] [PDF]

				J. R. Kocks, H. Adler, H. Danzer, K. Hoffmann, D. Jonigk, U. Lehmann, and R. Forster Chemokine Receptor CCR7 Contributes to a Rapid and Efficient Clearance of Lytic Murine {gamma}-Herpes Virus 68 from the Lung, Whereas Bronchus-Associated Lymphoid Tissue Harbors Virus during Latency J. Immunol., June 1, 2009; 182(11): 6861 - 6869. [Abstract] [Full Text] [PDF]

				M. Ottinger, D. Pliquet, T. Christalla, R. Frank, J. P. Stewart, and T. F. Schulz The Interaction of the Gammaherpesvirus 68 orf73 Protein with Cellular BET Proteins Affects the Activation of Cell Cycle Promoters J. Virol., May 1, 2009; 83(9): 4423 - 4434. [Abstract] [Full Text] [PDF]

				K. S. Gray, R. D. Allen III, M. L. Farrell, J. C. Forrest, and S. H. Speck Alternatively Initiated Gene 50/RTA Transcripts Expressed during Murine and Human Gammaherpesvirus Reactivation from Latency J. Virol., January 1, 2009; 83(1): 314 - 328. [Abstract] [Full Text] [PDF]

				N. Jarousse, B. Chandran, and L. Coscoy Lack of Heparan Sulfate Expression in B-Cell Lines: Implications for Kaposi's Sarcoma-Associated Herpesvirus and Murine Gammaherpesvirus 68 Infections J. Virol., December 15, 2008; 82(24): 12591 - 12597. [Abstract] [Full Text] [PDF]

				S. Hwang, T.-T. Wu, L. M. Tong, K. S. Kim, D. Martinez-Guzman, A. D. Colantonio, C. H. Uittenbogaart, and R. Sun Persistent Gammaherpesvirus Replication and Dynamic Interaction with the Host In Vivo J. Virol., December 15, 2008; 82(24): 12498 - 12509. [Abstract] [Full Text] [PDF]

				P. Dias, A. L. Shea, C. Inglis, F. Giannoni, L. N. Lee, and S. R. Sarawar Primary Clearance of Murine Gammaherpesvirus 68 by PKC{theta}-/- CD8 T Cells Is Compromised in the Absence of Help from CD4 T Cells J. Virol., December 1, 2008; 82(23): 11970 - 11975. [Abstract] [Full Text] [PDF]

				F. Giannoni, A. Shea, C. Inglis, L. N. Lee, and S. R. Sarawar CD40 Engagement on Dendritic Cells, but Not on B or T Cells, Is Required for Long-Term Control of Murine Gammaherpesvirus 68 J. Virol., November 15, 2008; 82(22): 11016 - 11022. [Abstract] [Full Text] [PDF]

				H. Li, K. Ikuta, J. W. Sixbey, and S. A. Tibbetts A Replication-Defective Gammaherpesvirus Efficiently Establishes Long-Term Latency in Macrophages but Not in B Cells In Vivo J. Virol., September 1, 2008; 82(17): 8500 - 8508. [Abstract] [Full Text] [PDF]

				M. DeZalia and S. H. Speck Identification of Closely Spaced but Distinct Transcription Initiation Sites for the Murine Gammaherpesvirus 68 Latency-Associated M2 Gene J. Virol., August 1, 2008; 82(15): 7411 - 7421. [Abstract] [Full Text] [PDF]

				J. C. Forrest and S. H. Speck Establishment of B-Cell Lines Latently Infected with Reactivation-Competent Murine Gammaherpesvirus 68 Provides Evidence for Viral Alteration of a DNA Damage-Signaling Cascade J. Virol., August 1, 2008; 82(15): 7688 - 7699. [Abstract] [Full Text] [PDF]

				B. Gangadharan, M. A. Hoeve, J. E. Allen, B. Ebrahimi, S. M. Rhind, B. M. Dutia, and A. A. Nash Murine gammaherpesvirus-induced fibrosis is associated with the development of alternatively activated macrophages J. Leukoc. Biol., July 1, 2008; 84(1): 50 - 58. [Abstract] [Full Text] [PDF]

				L. M. Gargano, J. M. Moser, and S. H. Speck Role for MyD88 Signaling in Murine Gammaherpesvirus 68 Latency J. Virol., April 15, 2008; 82(8): 3853 - 3863. [Abstract] [Full Text] [PDF]

				D. Stapler, E. D. Lee, S. A. Selvaraj, A. G. Evans, L. S. Kean, S. H. Speck, C. P. Larsen, and S. Gangappa Expansion of Effector Memory TCR V{beta}4+CD8+ T Cells Is Associated with Latent Infection-Mediated Resistance to Transplantation Tolerance J. Immunol., March 1, 2008; 180(5): 3190 - 3200. [Abstract] [Full Text] [PDF]

				S. Fuse, W. Zhang, and E. J. Usherwood Control of Memory CD8+ T Cell Differentiation by CD80/CD86-CD28 Costimulation and Restoration by IL-2 during the Recall Response J. Immunol., January 15, 2008; 180(2): 1148 - 1157. [Abstract] [Full Text] [PDF]

				S. Guggemoos, D. Hangel, S. Hamm, A. Heit, S. Bauer, and H. Adler TLR9 Contributes to Antiviral Immunity during Gammaherpesvirus Infection J. Immunol., January 1, 2008; 180(1): 438 - 443. [Abstract] [Full Text] [PDF]

				B. Kayhan, E. J. Yager, K. Lanzer, T. Cookenham, Q. Jia, T.-T. Wu, D. L. Woodland, R. Sun, and M. A. Blackman A Replication-Deficient Murine {gamma}-Herpesvirus Blocked in Late Viral Gene Expression Can Establish Latency and Elicit Protective Cellular Immunity J. Immunol., December 15, 2007; 179(12): 8392 - 8402. [Abstract] [Full Text] [PDF]

				K. A. Smith, S. Efstathiou, and A. Cooke Murine Gammaherpesvirus-68 Infection Alters Self-Antigen Presentation and Type 1 Diabetes Onset in NOD Mice J. Immunol., December 1, 2007; 179(11): 7325 - 7333. [Abstract] [Full Text] [PDF]

				F. Kupresanin, J. Chow, A. Mount, C. M. Smith, P. G. Stevenson, and G. T. Belz Dendritic Cells Present Lytic Antigens and Maintain Function throughout Persistent {gamma}-Herpesvirus Infection J. Immunol., December 1, 2007; 179(11): 7506 - 7513. [Abstract] [Full Text] [PDF]

				J. C. Forrest, C. R. Paden, R. D. Allen III, J. Collins, and S. H. Speck ORF73-Null Murine Gammaherpesvirus 68 Reveals Roles for mLANA and p53 in Virus Replication J. Virol., November 1, 2007; 81(21): 11957 - 11971. [Abstract] [Full Text] [PDF]

				J. L. Weslow-Schmidt, N. A. Jewell, S. E. Mertz, J. P. Simas, J. E. Durbin, and E. Flano Type I Interferon Inhibition and Dendritic Cell Activation during Gammaherpesvirus Respiratory Infection J. Virol., September 15, 2007; 81(18): 9778 - 9789. [Abstract] [Full Text] [PDF]

				R. Hochreiter, C. Ptaschinski, S. L. Kunkel, and R. Rochford Murine gammaherpesvirus-68 productively infects immature dendritic cells and blocks maturation J. Gen. Virol., July 1, 2007; 88(7): 1896 - 1905. [Abstract] [Full Text] [PDF]

				A. Steed, T. Buch, A. Waisman, and H. W. Virgin IV Gamma Interferon Blocks Gammaherpesvirus Reactivation from Latency in a Cell Type-Specific Manner J. Virol., June 1, 2007; 81(11): 6134 - 6140. [Abstract] [Full Text] [PDF]

				R. Nascimento and R. M. E. Parkhouse Murine gammaherpesvirus 68 ORF20 induces cell-cycle arrest in G2 by inhibiting the Cdc2-cyclin B complex J. Gen. Virol., May 1, 2007; 88(5): 1446 - 1453. [Abstract] [Full Text] [PDF]

				S. Fuse, S. Bellfy, H. Yagita, and E. J. Usherwood CD8+ T Cell Dysfunction and Increase in Murine Gammaherpesvirus Latent Viral Burden in the Absence of 4-1BB Ligand J. Immunol., April 15, 2007; 178(8): 5227 - 5236. [Abstract] [Full Text] [PDF]

				I.-J. Kim, C. E. Burkum, T. Cookenham, P. L. Schwartzberg, D. L. Woodland, and M. A. Blackman Perturbation of B Cell Activation in SLAM-Associated Protein-Deficient Mice Is Associated with Changes in Gammaherpesvirus Latency Reservoirs J. Immunol., February 1, 2007; 178(3): 1692 - 1701. [Abstract] [Full Text] [PDF]

				J. M. Devlin, G. F. Browning, C. A. Hartley, N. C. Kirkpatrick, A. Mahmoudian, A. H. Noormohammadi, and J. R. Gilkerson Glycoprotein G is a virulence factor in infectious laryngotracheitis virus. J. Gen. Virol., October 1, 2006; 87(Pt 10): 2839 - 2847. [Abstract] [Full Text] [PDF]

				N. Gasper-Smith, I. Marriott, and K. L. Bost Murine {gamma}-Herpesvirus 68 Limits Naturally Occurring CD4+CD25+ T Regulatory Cell Activity following Infection J. Immunol., October 1, 2006; 177(7): 4670 - 4678. [Abstract] [Full Text] [PDF]

				S. Fuse, J. J. Obar, S. Bellfy, E. K. Leung, W. Zhang, and E. J. Usherwood CD80 and CD86 Control Antiviral CD8+ T-Cell Function and Immune Surveillance of Murine Gammaherpesvirus 68. J. Virol., September 1, 2006; 80(18): 9159 - 9170. [Abstract] [Full Text] [PDF]

				A. L. Steed, E. S. Barton, S. A. Tibbetts, D. L. Popkin, M. L. Lutzke, R. Rochford, and H. W. Virgin IV Gamma Interferon Blocks Gammaherpesvirus Reactivation from Latency J. Virol., January 1, 2006; 80(1): 192 - 200. [Abstract] [Full Text] [PDF]

				V. L. Tarakanova, F. Suarez, S. A. Tibbetts, M. A. Jacoby, K. E. Weck, J. L. Hess, S. H. Speck, and H. W. Virgin IV Murine Gammaherpesvirus 68 Infection Is Associated with Lymphoproliferative Disease and Lymphoma in BALB {beta}2 Microglobulin-Deficient Mice J. Virol., December 1, 2005; 79(23): 14668 - 14679. [Abstract] [Full Text] [PDF]

				A. L. Mora, C. R. Woods, A. Garcia, J. Xu, M. Rojas, S. H. Speck, J. Roman, K. L. Brigham, and A. A. Stecenko Lung infection with {gamma}-herpesvirus induces progressive pulmonary fibrosis in Th2-biased mice Am J Physiol Lung Cell Mol Physiol, November 1, 2005; 289(5): L711 - L721. [Abstract] [Full Text] [PDF]

				E. Flano, B. Kayhan, D. L. Woodland, and M. A. Blackman Infection of Dendritic Cells by a {gamma}2-Herpesvirus Induces Functional Modulation J. Immunol., September 1, 2005; 175(5): 3225 - 3234. [Abstract] [Full Text] [PDF]

				B. J. Lee, F. Giannoni, A. Lyon, S. Yada, B. Lu, C. Gerard, and S. R. Sarawar Role of CXCR3 in the Immune Response to Murine Gammaherpesvirus 68 J. Virol., July 15, 2005; 79(14): 9351 - 9355. [Abstract] [Full Text] [PDF]

				F. Giannoni, A. B. Lyon, M. D. Wareing, P. B. Dias, and S. R. Sarawar Protein Kinase C {theta} Is Not Essential for T-Cell-Mediated Clearance of Murine Gammaherpesvirus 68 J. Virol., June 1, 2005; 79(11): 6808 - 6813. [Abstract] [Full Text] [PDF]

				J. S. May, J. Walker, S. Colaco, and P. G. Stevenson The Murine Gammaherpesvirus 68 ORF27 Gene Product Contributes to Intercellular Viral Spread J. Virol., April 15, 2005; 79(8): 5059 - 5068. [Abstract] [Full Text] [PDF]

				E. Flano, Q. Jia, J. Moore, D. L. Woodland, R. Sun, and M. A. Blackman Early Establishment of {gamma}-Herpesvirus Latency: Implications for Immune Control J. Immunol., April 15, 2005; 174(8): 4972 - 4978. [Abstract] [Full Text] [PDF]

				D. O. Willer and S. H. Speck Establishment and Maintenance of Long-Term Murine Gammaherpesvirus 68 Latency in B Cells in the Absence of CD40 J. Virol., March 1, 2005; 79(5): 2891 - 2899. [Abstract] [Full Text] [PDF]

				J. Herskowitz, M. A. Jacoby, and S. H. Speck The Murine Gammaherpesvirus 68 M2 Gene Is Required for Efficient Reactivation from Latently Infected B Cells J. Virol., February 15, 2005; 79(4): 2261 - 2273. [Abstract] [Full Text] [PDF]

				D. C. Braaten, R. L. Sparks-Thissen, S. Kreher, S. H. Speck, and H. W. Virgin IV An Optimized CD8+ T-Cell Response Controls Productive and Latent Gammaherpesvirus Infection J. Virol., February 15, 2005; 79(4): 2573 - 2583. [Abstract] [Full Text] [PDF]

				B. D. de Lima, J. S. May, S. Marques, J. P. Simas, and P. G. Stevenson Murine gammaherpesvirus 68 bcl-2 homologue contributes to latency establishment in vivo J. Gen. Virol., January 1, 2005; 86(1): 31 - 40. [Abstract] [Full Text] [PDF]

				F. B. Lopes, S. Colaco, J. S. May, and P. G. Stevenson Characterization of Murine Gammaherpesvirus 68 Glycoprotein B J. Virol., December 1, 2004; 78(23): 13370 - 13375. [Abstract] [Full Text] [PDF]

				X. Liang, Y. C. Shin, R. E. Means, and J. U. Jung Inhibition of Interferon-Mediated Antiviral Activity by Murine Gammaherpesvirus 68 Latency-Associated M2 Protein J. Virol., November 15, 2004; 78(22): 12416 - 12427. [Abstract] [Full Text] [PDF]

				J. Loh, D. A. Thomas, P. A. Revell, T. J. Ley, and H. W. Virgin IV Granzymes and Caspase 3 Play Important Roles in Control of Gammaherpesvirus Latency J. Virol., November 15, 2004; 78(22): 12519 - 12528. [Abstract] [Full Text] [PDF]

				J. P. Stewart, O. J. Silvia, I. M. D. Atkin, D. J. Hughes, B. Ebrahimi, and H. Adler In Vivo Function of a Gammaherpesvirus Virion Glycoprotein: Influence on B-Cell Infection and Mononucleosis J. Virol., October 1, 2004; 78(19): 10449 - 10459. [Abstract] [Full Text] [PDF]

				H. Deng, J. T. Chu, N.-H. Park, and R. Sun Identification of cis Sequences Required for Lytic DNA Replication and Packaging of Murine Gammaherpesvirus 68 J. Virol., September 1, 2004; 78(17): 9123 - 9131. [Abstract] [Full Text] [PDF]

				T. M. Rickabaugh, H. J. Brown, D. Martinez-Guzman, T.-T. Wu, L. Tong, F. Yu, S. Cole, and R. Sun Generation of a Latency-Deficient Gammaherpesvirus That Is Protective against Secondary Infection J. Virol., September 1, 2004; 78(17): 9215 - 9223. [Abstract] [Full Text] [PDF]

				J. Douglas, B. Dutia, S. Rhind, J. P. Stewart, and S. J. Talbot Expression in a Recombinant Murid Herpesvirus 4 Reveals the In Vivo Transforming Potential of the K1 Open Reading Frame of Kaposi's Sarcoma-Associated Herpesvirus J. Virol., August 15, 2004; 78(16): 8878 - 8884. [Abstract] [Full Text] [PDF]

				J. J. Obar, S. G. Crist, E. K. Leung, and E. J. Usherwood IL-15-Independent Proliferative Renewal of Memory CD8+ T Cells in Latent Gammaherpesvirus Infection J. Immunol., August 15, 2004; 173(4): 2705 - 2714. [Abstract] [Full Text] [PDF]

				R. L. Sparks-Thissen, D. C. Braaten, S. Kreher, S. H. Speck, and H. W. Virgin IV An Optimized CD4 T-Cell Response Can Control Productive and Latent Gammaherpesvirus Infection J. Virol., July 1, 2004; 78(13): 6827 - 6835. [Abstract] [Full Text] [PDF]

				J. S. McClellan, S. A. Tibbetts, S. Gangappa, K. A. Brett, and H. W. Virgin IV Critical Role of CD4 T Cells in an Antibody-Independent Mechanism of Vaccination against Gammaherpesvirus Latency J. Virol., July 1, 2004; 78(13): 6836 - 6845. [Abstract] [Full Text] [PDF]

				B. M. Dutia, D. J. Roy, B. Ebrahimi, B. Gangadharan, S. Efstathiou, J. P. Stewart, and A. A. Nash Identification of a region of the virus genome involved in murine gammaherpesvirus 68-induced splenic pathology J. Gen. Virol., June 1, 2004; 85(6): 1393 - 1400. [Abstract] [Full Text] [PDF]

				D. Verzijl, C. P. Fitzsimons, M. van Dijk, J. P. Stewart, H. Timmerman, M. J. Smit, and R. Leurs Differential Activation of Murine Herpesvirus 68- and Kaposi's Sarcoma-Associated Herpesvirus-Encoded ORF74 G Protein-Coupled Receptors by Human and Murine Chemokines J. Virol., April 1, 2004; 78(7): 3343 - 3351. [Abstract] [Full Text] [PDF]

				E. Flano, C. L. Hardy, I.-J. Kim, C. Frankling, M. A. Coppola, P. Nguyen, D. L. Woodland, and M. A. Blackman T Cell Reactivity during Infectious Mononucleosis and Persistent Gammaherpesvirus Infection in Mice J. Immunol., March 1, 2004; 172(5): 3078 - 3085. [Abstract] [Full Text] [PDF]

				A. C. Townsley, B. M. Dutia, and A. A. Nash The M4 Gene of Murine Gammaherpesvirus Modulates Productive and Latent Infection In Vivo J. Virol., January 15, 2004; 78(2): 758 - 767. [Abstract] [Full Text] [PDF]

				J. J. Obar, S. G. Crist, D. C. Gondek, and E. J. Usherwood Different Functional Capacities of Latent and Lytic Antigen-Specific CD8 T Cells in Murine Gammaherpesvirus Infection J. Immunol., January 15, 2004; 172(2): 1213 - 1219. [Abstract] [Full Text] [PDF]

				J. S. May, H. M. Coleman, B. Smillie, S. Efstathiou, and P. G. Stevenson Forced lytic replication impairs host colonization by a latency-deficient mutant of murine gammaherpesvirus-68 J. Gen. Virol., January 1, 2004; 85(1): 137 - 146. [Abstract] [Full Text] [PDF]

				S. F. Elsawa and K. L. Bost Murine {gamma}-Herpesvirus-68-Induced IL-12 Contributes to the Control of Latent Viral Burden, but Also Contributes to Viral-Mediated Leukocytosis J. Immunol., January 1, 2004; 172(1): 516 - 524. [Abstract] [Full Text] [PDF]

				E. Bortz, J. P. Whitelegge, Q. Jia, Z. H. Zhou, J. P. Stewart, T.-T. Wu, and R. Sun Identification of Proteins Associated with Murine Gammaherpesvirus 68 Virions J. Virol., December 15, 2003; 77(24): 13425 - 13432. [Abstract] [Full Text] [PDF]

				P. Fowler, S. Marques, J. P. Simas, and S. Efstathiou ORF73 of murine herpesvirus-68 is critical for the establishment and maintenance of latency J. Gen. Virol., December 1, 2003; 84(12): 3405 - 3416. [Abstract] [Full Text] [PDF]

				N. J. Moorman, D. O. Willer, and S. H. Speck The Gammaherpesvirus 68 Latency-Associated Nuclear Antigen Homolog Is Critical for the Establishment of Splenic Latency J. Virol., October 1, 2003; 77(19): 10295 - 10303. [Abstract] [Full Text] [PDF]

				D. Martinez-Guzman, T. Rickabaugh, T.-T. Wu, H. Brown, S. Cole, M. J. Song, L. Tong, and R. Sun Transcription Program of Murine Gammaherpesvirus 68 J. Virol., October 1, 2003; 77(19): 10488 - 10503. [Abstract] [Full Text] [PDF]

				A. I. Macrae, E. J. Usherwood, S. M. Husain, E. Flano, I.-J. Kim, D. L. Woodland, A. A. Nash, M. A. Blackman, J. T. Sample, and J. P. Stewart Murid Herpesvirus 4 Strain 68 M2 Protein Is a B-Cell-Associated Antigen Important for Latency but Not Lymphocytosis J. Virol., September 1, 2003; 77(17): 9700 - 9709. [Abstract] [Full Text] [PDF]

				D. O. Willer and S. H. Speck Long-Term Latent Murine Gammaherpesvirus 68 Infection Is Preferentially Found within the Surface Immunoglobulin D-Negative Subset of Splenic B Cells In Vivo J. Virol., August 1, 2003; 77(15): 8310 - 8321. [Abstract] [Full Text] [PDF]

				I.-J. Kim, E. Flano, D. L. Woodland, F. E. Lund, T. D. Randall, and M. A. Blackman Maintenance of Long Term {gamma}-Herpesvirus B Cell Latency Is Dependent on CD40-Mediated Development of Memory B Cells J. Immunol., July 15, 2003; 171(2): 886 - 892. [Abstract] [Full Text] [PDF]

				S. Marques, S. Efstathiou, K. G. Smith, M. Haury, and J. P. Simas Selective Gene Expression of Latent Murine Gammaherpesvirus 68 in B Lymphocytes J. Virol., July 1, 2003; 77(13): 7308 - 7318. [Abstract] [Full Text] [PDF]

				I. V. Pavlova, H. W. Virgin IV, and S. H. Speck Disruption of Gammaherpesvirus 68 Gene 50 Demonstrates that Rta Is Essential for Virus Replication J. Virol., May 15, 2003; 77(10): 5731 - 5739. [Abstract] [Full Text] [PDF]

				L. F. van Dyk, H. W. Virgin IV, and S. H. Speck Maintenance of Gammaherpesvirus Latency Requires Viral Cyclin in the Absence of B Lymphocytes J. Virol., May 1, 2003; 77(9): 5118 - 5126. [Abstract] [Full Text] [PDF]

				E. Flano, I.-J. Kim, J. Moore, D. L. Woodland, and M. A. Blackman Differential {gamma}-Herpesvirus Distribution in Distinct Anatomical Locations and Cell Subsets During Persistent Infection in Mice J. Immunol., April 1, 2003; 170(7): 3828 - 3834. [Abstract] [Full Text] [PDF]

				S. F. Elsawa, W. Taylor, C. C. Petty, I. Marriott, J. V. Weinstock, and K. L. Bost Reduced CTL Response and Increased Viral Burden in Substance P Receptor-Deficient Mice Infected with Murine {gamma}-Herpesvirus 68 J. Immunol., March 1, 2003; 170(5): 2605 - 2612. [Abstract] [Full Text] [PDF]

				H. M. Coleman, B. d. Lima, V. Morton, and P. G. Stevenson Murine Gammaherpesvirus 68 Lacking Thymidine Kinase Shows Severe Attenuation of Lytic Cycle Replication In Vivo but Still Establishes Latency J. Virol., February 15, 2003; 77(4): 2410 - 2417. [Abstract] [Full Text] [PDF]

				K. Blasdell, C. McCracken, A. Morris, A. A. Nash, M. Begon, M. Bennett, and J. P. Stewart The wood mouse is a natural host for Murid herpesvirus 4 J. Gen. Virol., January 1, 2003; 84(1): 111 - 113. [Abstract] [Full Text] [PDF]

				K. K. Jensen, S.-C. Chen, R. W. Hipkin, M. T. Wiekowski, M. A. Schwarz, C.-C. Chou, J. P. Simas, A. Alcami, and S. A. Lira Disruption of CCL21-Induced Chemotaxis In Vitro and In Vivo by M3, a Chemokine-Binding Protein Encoded by Murine Gammaherpesvirus 68 J. Virol., December 6, 2002; 77(1): 624 - 630. [Abstract] [Full Text] [PDF]

				E. Flano, I.-J. Kim, D. L. Woodland, and M. A. Blackman {gamma}-Herpesvirus Latency Is Preferentially Maintained in Splenic Germinal Center and Memory B Cells J. Exp. Med., November 18, 2002; 196(10): 1363 - 1372. [Abstract] [Full Text] [PDF]

				S. Gangappa, S. B. Kapadia, S. H. Speck, and H. W. Virgin IV Antibody to a Lytic Cycle Viral Protein Decreases Gammaherpesvirus Latency in B-Cell-Deficient Mice J. Virol., October 17, 2002; 76(22): 11460 - 11468. [Abstract] [Full Text] [PDF]

				B. T. Seet and G. McFadden Viral chemokine-binding proteins J. Leukoc. Biol., July 1, 2002; 72(1): 24 - 34. [Abstract] [Full Text] [PDF]

				S. A. Tibbetts, L. F. van Dyk, S. H. Speck, and H. W. Virgin IV Immune Control of the Number and Reactivation Phenotype of Cells Latently Infected with a Gammaherpesvirus J. Virol., June 14, 2002; 76(14): 7125 - 7132. [Abstract] [Full Text] [PDF]

				E. T. Clambey, H. W. Virgin IV, and S. H. Speck Characterization of a Spontaneous 9.5-Kilobase-Deletion Mutant of Murine Gammaherpesvirus 68 Reveals Tissue-Specific Genetic Requirements for Latency J. Virol., June 5, 2002; 76(13): 6532 - 6544. [Abstract] [Full Text] [PDF]

				I.-J. Kim, E. Flano, D. L. Woodland, and M. A. Blackman Antibody-Mediated Control of Persistent {gamma}-Herpesvirus Infection J. Immunol., April 15, 2002; 168(8): 3958 - 3964. [Abstract] [Full Text] [PDF]

				S. Vacheron, S. A. Luther, and H. Acha-Orbea Preferential Infection of Immature Dendritic Cells and B Cells by Mouse Mammary Tumor Virus J. Immunol., April 1, 2002; 168(7): 3470 - 3476. [Abstract] [Full Text] [PDF]

				H. Liu, S. Andreansky, G. Diaz, T. Hogg, and P. C. Doherty Reduced Functional Capacity of CD8+ T Cells Expanded by Post-Exposure Vaccination of {gamma}-Herpesvirus-Infected CD4-Deficient Mice J. Immunol., April 1, 2002; 168(7): 3477 - 3483. [Abstract] [Full Text] [PDF]

				M. A. Jacoby, H. W. Virgin IV, and S. H. Speck Disruption of the M2 Gene of Murine Gammaherpesvirus 68 Alters Splenic Latency following Intranasal, but Not Intraperitoneal, Inoculation J. Virol., February 15, 2002; 76(4): 1790 - 1801. [Abstract] [Full Text] [PDF]

				C. M. Payne, C. J. Heggie, D. G. Brownstein, J. P. Stewart, and J. P. Quinn Role of Tachykinins in the Host Response to Murine Gammaherpesvirus Infection J. Virol., November 1, 2001; 75(21): 10467 - 10471. [Abstract] [Full Text] [PDF]

				A. Bridgeman, P. G. Stevenson, J. P. Simas, and S. Efstathiou A Secreted Chemokine Binding Protein Encoded by Murine Gammaherpesvirus-68 Is Necessary for the Establishment of a Normal Latent Load J. Exp. Med., August 6, 2001; 194(3): 301 - 312. [Abstract] [Full Text] [PDF]

				H. Adler, M. Messerle, and U. H. Koszinowski Virus Reconstituted from Infectious Bacterial Artificial Chromosome (BAC)-Cloned Murine Gammaherpesvirus 68 Acquires Wild-Type Properties In Vivo Only after Excision of BAC Vector Sequences J. Virol., June 15, 2001; 75(12): 5692 - 5696. [Abstract] [Full Text]

				R. Rochford, M. L. Lutzke, R. S. Alfinito, A. Clavo, and R. D. Cardin Kinetics of Murine Gammaherpesvirus 68 Gene Expression following Infection of Murine Cells in Culture and in Mice J. Virol., June 1, 2001; 75(11): 4955 - 4963. [Abstract] [Full Text]

				A. I. Macrae, B. M. Dutia, S. Milligan, D. G. Brownstein, D. J. Allen, J. Mistrikova, A. J. Davison, A. A. Nash, and J. P. Stewart Analysis of a Novel Strain of Murine Gammaherpesvirus Reveals a Genomic Locus Important for Acute Pathogenesis J. Virol., June 1, 2001; 75(11): 5315 - 5327. [Abstract] [Full Text]

				M. N. Wakeling, D. J. Roy, A. A. Nash, and J. P. Stewart Characterization of the murine gammaherpesvirus 68 ORF74 product: a novel oncogenic G protein-coupled receptor J. Gen. Virol., May 1, 2001; 82(5): 1187 - 1197. [Abstract] [Full Text]

				E. J. Usherwood, D. J. Roy, K. Ward, S. L. Surman, B. M. Dutia, M. A. Blackman, J. P. Stewart, and D. L. Woodland Control of Gammaherpesvirus Latency by Latent Antigen-specific CD8+ T Cells J. Exp. Med., September 25, 2000; 192(7): 943 - 952. [Abstract] [Full Text] [PDF]

				S. R. Sarawar, B. J. Lee, S. K. Reiter, and S. P. Schoenberger Stimulation via CD40 can substitute for CD4 T cell function in preventing reactivation of a latent herpesvirus PNAS, May 22, 2001; 98(11): 6325 - 6329. [Abstract] [Full Text] [PDF]

				S. Gangappa, L. F. van Dyk, T. J. Jewett, S. H. Speck, and H. W. Virgin IV Identification of the In Vivo Role of a Viral bcl-2 J. Exp. Med., April 1, 2002; 195(7): 931 - 940. [Abstract] [Full Text] [PDF]

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Flaño, E. Articles by Blackman, M. A. Search for Related Content PubMed PubMed Citation Articles by Flaño, E. Articles by Blackman, M. A.